Opening book details…
About this Medicine article
A5-02: Targeted therapy against VEGFR and/or EGFR signaling with AZD2171, vandetanib, and gefitinib as part of a combined modality approach for the treatment of non-small-cell lung cancer by O'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- O'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S.
- Publisher
- Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1556-1380)
- Published
- 2007
- Field
- Medicine (Health Sciences)